# 31722-276-32 · Bupivacaine Hydrochloride Injection · Aspiro Pharma Limited — FDA drug shortage duration tracker

For 31722-276-32 · Bupivacaine Hydrochloride Injection · Aspiro Pharma Limited, package ndc is 31722-276-32; generic name is Bupivacaine Hydrochloride Injection; manufacturer is Aspiro Pharma Limited; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 31722-276-32 _(verified: appears in the quote below)_
- **Generic name:** Bupivacaine Hydrochloride Injection _(verified: appears in the quote below)_
- **Manufacturer:** Aspiro Pharma Limited _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 02/20/2018 _(verified: appears in the quote below)_
- **Last update date:** 07/17/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3115 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/20/2018", "package_ndc": "31722-276-32", "generic_name": "Bupivacaine Hydrochloride Injection", "contact_info": "732-529-0430, customerservice@camberpharma.com", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "07/17/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)", "company_name": "Aspiro Pharma Limited", "status": "Current"

### Status

> "update_date": "07/17/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)", "company_name": "Aspiro Pharma Limited", "status": "Current"

### Last update date

> "update_date": "07/17/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)", "company_name": "Aspiro Pharma Limited", "status": "Current"

### Dosage form

> "update_date": "07/17/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)", "company_name": "Aspiro Pharma Limited", "status": "Current"

### Therapeutic category

> "update_date": "07/17/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)", "company_name": "Aspiro Pharma Limited", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).